Involvement of heregulin/HER3 in the primary culture of human urothelial cancer

Journal of Urology

Volumn 190, Issue 1, 2013, Pages 302-310

  Okuyama, Hiroaki ^a   Yoshida, Takahiro ^a,b   Endo, Hiroko ^a   Nakayama, Masashi ^a   Nonomura, Norio ^b   Nishimura, Kazuo ^a   Inoue, Masahiro ^a,b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

carcinoma, transitional cell; neuregulin 1; primary cell culture; urinary bladder; urothelium

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; ERLOTINIB; LAPATINIB; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHOTREXATE; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; VINBLASTINE;

ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURGERY; CANCER TISSUE; CLINICAL PROTOCOL; COLORECTAL CANCER; CONTROLLED STUDY; CYSTECTOMY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOLATION PROCEDURE; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PRIORITY JOURNAL; TISSUE CULTURE; TUMOR SPHEROID; WESTERN BLOTTING; XENOGRAFT;

BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR TARGETED THERAPY; NEUREGULIN-1; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-3; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 84878886137     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.12.106     Document Type: Article

References (27)

1. J. Barretina, G. Caponigro, N. Stransky The cancer cell line encyclopedia enables predictive modeling of anticancer drug sensitivity Nature 483 2012 603
2. M. Seshadri, M. Merzianu, H. Tang Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenografts Cancer Biol Ther 8 2009 2275
3. X.Y. Fu, J.M. Besterman, A. Monosov Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens Proc Natl Acad Sci U S A 88 1991 9345
4. T. Furukawa, T. Kubota, R.M. Hoffman Clinical applications of the histoculture drug response assay Clin Cancer Res 1 1995 305
5. H. Kobayashi, K. Tanisaka, O. Doi An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures Int J Oncol 11 1997 449
6. J. Kondo, H. Endo, H. Okuyama Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer Proc Natl Acad Sci U S A 108 2011 6235
7. C. Bianchi, S. Bombelli, F. Raimondo Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 Am J Pathol 176 2010 1660
8. J. Debnath, J.S. Brugge Modelling glandular epithelial cancers in three-dimensional cultures Nat Rev Cancer 5 2005 675
9. S.T. Lee-Hoeflich, L. Crocker, E. Yao A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy Cancer Res 68 2008 5878
10. R. Chen, M.C. Nishimura, S.M. Bumbaca A hierarchy of self-renewing tumor-initiating cell types in glioblastoma Cancer Cell 17 2010 362
11. L. Wang, T.C. Schulz, E.S. Sherrer Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling Blood 110 2007 4111
12. B. Schoeberl, E.A. Pace, J.B. Fitzgerald Therapeutically targeting erbB3: a key node in ligand-induced activation of the erbB receptor-PI3K axis Sci Signal 2 2009 ra31
13. T.R. Wilson, D.Y. Lee, L. Berry Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers Cancer Cell 20 2011 158
14. R.T. Bryan, C. Tselepis Cadherin switching and bladder cancer J Urol 184 2010 423
15. D.J. Weaver, B.A. Barrett, G. Ross Jr Transitional explant reduction assay - a new in vitro testing system for intravesical chemotherapy J Urol 135 1986 386
16. P. Gontero, J.M. Sargent, D.J. Hopster Ex vivo chemosensitivity to mitomycin C in bladder cancer and its relationship with P-glycoprotein and apoptotic factors Anticancer Res 22 2002 4073
17. C. Mothersill, D. Rea, E.G. Wright Individual variation in the production of a bystander signal following irradiation of primary cultures of normal human urothelium Carcinogenesis 22 2001 1465
18. J.P. Burgues, L. Gomez, J.L. Pontones A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids Eur Urol 51 2007 962
19. H.H. Seifert, A. Meyer, M.V. Cronauer A new and reliable culture system for superficial low-grade urothelial carcinoma of the bladder World J Urol 25 2007 297
20. K. Hinohara, S. Kobayashi, H. Kanauchi ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer Proc Natl Acad Sci U S A 109 2012 6584
21. K.E. O'Reilly, F. Rojo, Q.B. She mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates AKT Cancer Res 66 2006 1500
22. Y. Shi, H. Yan, P. Frost Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/ phosphatidylinositol 3-kinase cascade Mol Cancer Ther 4 2005 1533
23. G. Scaefer, L. Haber, L.M. Crocker A two-in one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies Cancer Cell 20 2011 472
24. J.T. Garrett, M.G. Olivares, C. Rinehart Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase Proc Natl Acad Sci U S A 108 2011 5021
25. A.A. Memon, B.S. Sorensen, P. Melgard Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients Br J Cancer 91 2004 2034
26. A.A. Memon, B.S. Sorensen, P. Meldgaard The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients Br J Cancer 94 2006 1703
27. N.H. Chow, S.H. Chan, T.S. Tzai Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder Clin Cancer Res 7 2001 1957